Advanced search
Add to list

Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: In vitro studies with tolbutamide and (S)-warfarin using human liver microsomes.

Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Hemeryck, Alex, et al. “Inhibition of CYP2C9 by Selective Serotonin Reuptake Inhibitors: In Vitro Studies with Tolbutamide and (S)-Warfarin Using Human Liver Microsomes.” EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol. 54 (12, 1999, pp. 947–51.
APA
Hemeryck, A., DE VRIENDT, C., & Belpaire, F. (1999). Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: In vitro studies with tolbutamide and (S)-warfarin using human liver microsomes. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 54 (12, 947–951.
Chicago author-date
Hemeryck, Alex, C DE VRIENDT, and Frans Belpaire. 1999. “Inhibition of CYP2C9 by Selective Serotonin Reuptake Inhibitors: In Vitro Studies with Tolbutamide and (S)-Warfarin Using Human Liver Microsomes.” EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 54 (12: 947–51.
Chicago author-date (all authors)
Hemeryck, Alex, C DE VRIENDT, and Frans Belpaire. 1999. “Inhibition of CYP2C9 by Selective Serotonin Reuptake Inhibitors: In Vitro Studies with Tolbutamide and (S)-Warfarin Using Human Liver Microsomes.” EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 54 (12: 947–951.
Vancouver
1.
Hemeryck A, DE VRIENDT C, Belpaire F. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: In vitro studies with tolbutamide and (S)-warfarin using human liver microsomes. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 1999;54 (12:947–51.
IEEE
[1]
A. Hemeryck, C. DE VRIENDT, and F. Belpaire, “Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: In vitro studies with tolbutamide and (S)-warfarin using human liver microsomes.,” EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol. 54 (12, pp. 947–951, 1999.
@article{115507,
  author       = {{Hemeryck, Alex and DE VRIENDT, C and Belpaire, Frans}},
  issn         = {{0031-6970}},
  journal      = {{EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY}},
  language     = {{eng}},
  pages        = {{947--951}},
  title        = {{Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: In vitro studies with tolbutamide and (S)-warfarin using human liver microsomes.}},
  volume       = {{54 (12}},
  year         = {{1999}},
}

Web of Science
Times cited: